Please login to the form below
Biden administration
This page shows the latest Biden administration news and features for those working in and with pharma, biotech and healthcare.
Fauci addresses need for pan-coronavirus and intranasal vaccines to combat COVID-19 variants
Dr Anthony Fauci, chief medical advisor to the Biden administration, addressed the press in a White House speech to shed light on the direction of next-generation vaccines. ... The US Food and Drug Administration (FDA) gave a recommendation at the end of
Latest news
-
The White House reveals its ‘Cancer Cabinet’ line-up as its Moonshot initiative progresses
The White House has announced its new ‘Cancer Cabinet’ line-up, which is part of President Joe Biden’s Cancer Moonshot initiative. ... During his time as vice president with the Obama administration in 2016, Biden began the Moonshot initiative
-
FDA experts to evaluate Pfizer-BioNTech COVID-19 booster
before the Biden Administration said the booster programme is to begin. ... On 25 August, Pfizer/BioNTech announced the initiation of a supplemental biologics licence application to the US Food and Drug Administration (FDA) for a booster dose of Comirnaty
-
FDA’s director and deputy director of its Office of Vaccines Research & Review resign
US – has stirred conjecture that it was the Biden administration’s vaccine booster plan that prompted the move. ... Last week the White House had to roll back comments made by President Biden that the administration was considering allowing people to
-
US announces $3bn funding boost for antiviral COVID-19 treatments
The Biden Administration has said the funding will go toward the discovery, development and manufacturing of antiviral medicines as part of its ‘whole-of-government’ strategy to develop next-generation ... The deal, worth $1.2bn, is contingent upon
-
US backs proposal to waive IP protection for COVID-19 vaccines
The Biden-Harris Administration is backing a proposal from the World Trade Organization (WTO), supported by South Africa and India, that would temporarily remove IP protections on COVID-19 vaccines. ... However, in a statement, US Trade Representative
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Achieving communication excellence by targeting the right channel at the right time
- Environment: where does the pharmaceutical industry stand?
- FDA approves Incyte’s Pemazyre as first targeted drug for bile duct cancer
- Novartis reports death of two patients treated with Zolgensma
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
